No Data
No Data
2 ASX Penny Stocks to Consider Buying While Their Prices Are This Cheap
Investors with a high risk tolerance might want to consider adding the two ASX penny stocks in this article to a balanced portfolio.
Why Appen, Mayne Pharma, Playside, and PYC Shares Are Storming Higher
It has been a tough finish to the week for the S&P/ASX 200 Index (ASX: XJO). In afternoon trade, the benchmark index is down 1.2% to 7,719 points.
PYC Therapeutics Secures US FDA Orphan Drug Designation for Eye Disease Medication Candidate; Shares Fall 4%
PYC Therapeutics (ASX:PYC) secured an orphaned drug designation from the US Food and Drug Administration for the use of its medicinal candidate PYC-001 in patients with autosomal dominant optic atroph
Guess Which ASX All Ords Insider Just Bought 50 Million Shares in Their Company
It can be useful for investors to keep an eye on which shares have experienced meaningful insider buying.
PYC Therapeutics Started at Buy by Bell Potter >PYC.AU
PYC Therapeutics Started at Buy by Bell Potter >PYC.AU
PYC Therapeutics Started With A$0.17/Share Target Price by Bell Potter>PYC.AU
PYC Therapeutics Started With A$0.17/Share Target Price by Bell Potter>PYC.AU
No Data